Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Neoplasms × vistusertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Stomach Neoplasms 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Recurrence 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Cancer 1 Meningioma 1 Lung Neoplasms 1 Glioblastoma 1 Estrogen Receptor Positive Breast Cancer 1 Endometrial Neoplasms 1 Disease 1 DLBCL 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma 1 Advanced Solid Malignancies 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1 Adenocarcinoma 1

Interventions

Paclitaxel 80 Carboplatin 65 pembrolizumab 62 Cisplatin 25 Bevacizumab 25 Letrozole 21 Doxorubicin 20 Radiotherapy 19 olaparib 16 lenvatinib 16 Taxes 16 Megestrol Acetate 16 Docetaxel 15 dostarlimab 14 Specimen Handling 14 Nivolumab 14 Metformin 13 Magnetic Resonance Spectroscopy 12 durvalumab 11 Fulvestrant 11 temsirolimus 10 Medroxyprogesterone Acetate 10 Indocyanine Green 10 abemaciclib 9 Trastuzumab 9 Radiation 9 Gemcitabine 9 Brachytherapy 9 Biopsy 9 Observation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02730923 2024-02-13

VICTORIA

Centre Leon Berard

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡